Evidence map›Paper›PMID 37852980›Full record

ArticleNature communications2023

The ClpX protease is essential for inactivating the CI master repressor and completing prophage induction in Staphylococcus aureus.

Mohammed A Thabet, José R Penadés, Andreas F Haag

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. mLife · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Mohammed A ThabetSchool of Infection & Immunity, University of Glasgow, G12 8TA, Glasgow, UK.ORCID http://orcid.org/0000-0001-8644-7855
José R PenadésMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, SW7 2AZ, UK.ORCID http://orcid.org/0000-0002-6439-5262
Andreas F HaagSchool of Infection & Immunity, University of Glasgow, G12 8TA, Glasgow, UK. afh22@st-andrews.ac.uk.ORCID http://orcid.org/0000-0002-6783-0231
Al Baha University · SAImperial College London · GBUniversity of St Andrews · GB

Funding

Biotechnology and Biological Sciences Research Council BB/N002873/1Biotechnology and Biological Sciences Research Council BB/S003835/1Medical Research Council MR/M003876/1Medical Research Council MR/S00940X/1Medical Research Council MR/S00940X/2Wellcome TrustWellcome Trust 201531/Z/16/Z
6 · The paper itself

Abstract

Bacteriophages (phages) are the most abundant biological entities on Earth, exerting a significant influence on the dissemination of bacterial virulence, pathogenicity, and antimicrobial resistance. Temperate phages integrate into the bacterial chromosome in a dormant state through intricate regulatory mechanisms. These mechanisms repress lytic genes while facilitating the expression of integrase and the CI master repressor. Upon bacterial SOS response activation, the CI repressor undergoes auto-cleavage, producing two fragments with the N-terminal domain (NTD) retaining significant DNA-binding ability. The process of relieving CI NTD repression, essential for prophage induction, remains unknown. Here we show a specific interaction between the ClpX protease and CI NTD repressor fragment of phages Ф11 and 80α in Staphylococcus aureus. This interaction is necessary and sufficient for prophage activation after SOS-mediated CI auto-cleavage, defining the final stage in the prophage induction cascade. Our findings unveil unexpected roles of bacterial protease ClpX in phage biology.

Indexed as

BacteriophagesVirus ActivationPeptide HydrolasesProphagesStaphylococcus aureusPeptide Hydrolases

Identifiers

PMID37852980
PMCPMC10584840
OpenAlexW4387735503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.